Compound Inhibition Assay
Compound Inhibition Assay - Related Videos
03:37
A Deferred Growth Inhibition Assay to Evaluate the Effect of Bacteria-Derived Antimicrobial Compounds
0 Views •
2025
This video showcases the deferred growth inhibition assay, used to investigate how antimicrobial compounds produced by one type of bacteria affect another competing bacterial strain.
09:29
Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds
0 Views •
Cited by 45 •
2015
Here, we present a protocol that examines specific steps of the viral entry to identify and evaluate novel antiviral agents.
02:47
A Viral Attachment Assay for Screening of Antiviral Compounds
0 Views •
2025
This video demonstrates a viral attachment assay for screening antiviral compounds. Using genetically modified hepatitis C virus and luciferase, it assesses inhibitory effects on viral attachment, as indicated by lower light intensity in co-treated wells compared to wells treated with the virus alone.
06:08
A Charcoal Agar Resazurin Assay to Evaluate Test Compound Activity Against Mycobacteria
0 Views •
2025
This video showcases the Charcoal Agar Resazurin Assay (CARA) for evaluating the activity of antimicrobial compounds against Mycobacterium tuberculosis. CARA aids in assessing the efficacy of these compounds by gauging their impact on bacterial growth and distinguishing between bactericidal and bacteriostatic effects.
03:19
An Assay to Measure Influenza Neuraminidase Inhibition Antibody Titers
0 Views •
2025
This video demonstrates an assay measuring influenza neuraminidase (NA) inhibiting antibody titers in a serum sample. A serum sample containing antibodies against NA is added to a fetuin-coated microwell plate. Upon adding the virus, the antibodies prevent viral NA from cleaving fetuin and exposing its galactose moiety. A peroxidase-conjugated lectin is then added, which binds to the exposed galactose. The NA-inhibiting antibody titer is determined using a colorimetric test, where a peroxidase...
FAQs
The target is exposed to progressively higher compound concentrations while a measurable activity signal is monitored. If the signal decreases as concentration rises, the pattern supports concentration-dependent inhibition. Comparing the response across the concentration range helps researchers distinguish weak effects from stronger activity and provides the dose-response information needed for quantitative potency analysis.
Competition occurs when a compound interferes with the interaction between a biological target and its substrate or ligand. In an enzyme assay, this can reduce substrate processing, while receptor-focused measurements can reflect disrupted ligand interaction. Examining this behavior helps researchers characterize how a compound may affect target activity rather than simply recording that activity changed.
An IC50 value summarizes the compound concentration associated with a defined level of inhibition in the assay. It allows researchers to compare apparent potency among compounds tested under the same conditions. Because the value comes from dose-response data, it should be interpreted alongside the assay design and target interaction being measured, rather than as an isolated description of molecular behavior.
Testing a compound against more than one target can reveal whether its inhibitory activity is selective or broadly distributed. This comparison adds context to potency measurements by showing whether the compound preferentially affects the intended enzyme or receptor. Selectivity information helps researchers characterize molecular interactions and decide which candidates merit more focused validation.
A typical workflow places the biological target under controlled conditions, exposes it to a range of compound concentrations, and measures a signal linked to target activity. Researchers then compare signal changes across concentrations and analyze the resulting dose-response relationship. The workflow can be adapted to enzyme or receptor targets by selecting the relevant substrate, ligand, or activity readout.
Researchers use compound inhibition assays to identify compounds that reduce a target's activity, compare their apparent potency, and prioritize candidates for further study. The resulting measurements also support early assessment of target engagement and selectivity. In this way, the assay connects an observable biological response with decisions about which compounds deserve additional validation.
Dose-response measurements can indicate how strongly a compound affects a biological target and support calculation of an IC50 value. Comparisons among compounds can reveal relative potency, while testing relevant targets can provide evidence about selectivity. Together, these outcomes help characterize compound-target interactions and organize candidates for subsequent biological investigation.